Preliminary Program: Tuesday, May 25
7:30 a.m.-6.p.m.
Registration/Course Enrollment Open
8 a.m.-Noon
CME Courses 65-67
8 a.m.-5 p.m.
CME Course 68
9 a.m.-10:30 a.m.
Advances in Medicine
AM03. Movement Disorders in Psychiatric Patients Chair: Laura Marsh, M.D.
Case Conference 2
Michael Myers, M.D., on Death of a Physician by Suicide (Open to APA members only.)
Forum
F03. Is a Game-Changing Psychotropic Too Much to Expect? Phil Ninan, M.D.
Lectures
L11. Addiction: Conflict Between Brain Circuits Nora D. Volkow, M.D., Frontiers of Science Lecture
L12. From Circuits to Cells to Molecular Regulation: Identifying Novel Targets for the Treatment of Psychotic Disorders Francine M. Benes, M.D.
Scientific and Clinical Reports
Session 14. Anxiety Disorders
SCR40. The Long-Term Treatment of Obsessive-Compulsive Disorder Afia Sadiq, M.D.
SCR41. Acute Treatment of Panic Disorder With Clonazepam or Paroxetine: A Randomized, Naturalistic Open Study Antonio Nardi, M.D.
SCR42. Recurrence of Panic Attacks Following Medication Discontinuation Svetoslav Hristov, M.D.
Small Interactive Sessions
SI09. Sheldon Benjamin, M.D., on Neuropsychiatric Assessment for General Psychiatrists
SI10. Mina K. Dulcan, M.D., on What's New in Child and Adolescent Psychiatry? (Meet the Author)
SI11. Philip R. Muskin M.D., on Requests to Evaluate Patients' Decisional Capacity in the Medical Setting: What Are They Really Asking For?
SI12. Carol C. Nadelson M.D., on Career Development for Women Psychiatry Residents—Challenges and Solutions (Open to APA resident members only.)
SI13. Jarrett W. Richardson M.D., on Psychiatric Issues in Palliative Care
Workshops
W87. Aging Heroically in An Urban Setting: The Diary of Jessie Sylvester The Beautiful Hills of Brooklyn Chair: David Preven, M.D.
W88. Transcranial Magnetic Stimulation (TMS) in the Treatment of Major Depression: A New Therapeutic Tool for Psychiatry Chair: John P. O'Reardon, M.D.
W89. Understanding CPT Coding and How Fees Are Calculated APA Committee on RBRVS, Codes, and Reimbursement; Chair: Ronald Burd, M.D.
W90. Practical Challenges for Psychiatrists Implementing the Recovery Model Chair: Mark Ragins, M.D.
W91. Cognitive-Behavioral and Psychodynamic Approaches to Medication Adherence in Severe Mental Illness Co-Chairs: Jesse Wright, M.D., Glen O. Gabbard, M.D.
W92. CAM or sCAM for Mood Disorders: Herbals and Beyond! Co-Chairs: Vishal Madaan, M.D., Diana Domnitei, M.D.
9 a.m.-Noon
Advances In Series 5
A05. Family Assessment and Intervention for Psychiatrists Chair: Gabor I. Keitner, M.D.
Advances In Series 6
A06. Advances in the Use of Antipsychotic Medications Co-Chairs: Anthony J. Rothschild, M.D., Kristina Deligiannidis, M.D.
Presidential Symposia
PS04. Recent Advances in Psychiatric Genetics: From Fundamental Discovery to Clinical Implication Co-Chairs: Alan Schatzberg, M.D., Solomon Snyder, M.D.
Opportunities and Pitfalls in Psychiatric Genetics in 2010: Clinical Implications Douglas F. Levinson, M.D.
The Genetics of Autism Daniel Geschwind, M.D.
A TOMM-40 Variable Length polyT Repeat Polymorphism, Inherited Through Evolution, Determines t he Age of Onset Distribution of Late-Onset Alzheimer's Disease Allen Roses, M.D.
New Directions in the Genetics of Bipolar Disorder Pamela Sklar, Ph.D.
Progress in Schizophrenia Genetics Patrick F. Sullivan, M.D.
Genomics of Ethnic Minority Groups: Pharmacogenomics of Depression in Mexican Americans Julio Licinio, M.D.
PS05. Health Reform and Psychiatry
Chair: Steven S. Sharfstein, M.D.
What Will Be the Role of the Public Sector Following Health Reform? Howard H. Goldman, M.D.
The Impact of Health Reform on Inpatient and Outpatient Psychiatric Practice Steven S. Sharfstein, M.D.
Health Care Reform: An Academic Exercise? Anthony Lehman, M.D.
The Role of Managed Care in Health Care Reform Henry Harbin, M.D.
The Impact of Health Reform on Psychotherapy by Psychiatrists Eric M. Plakun, M.D.
Symposia
S59. Psychiatrists in the World: Advocating for LGBT Mental Health
A.
The Psychiatrist as Advocate: The Case of AGLP Mary Barber, M.D.
B.
The GAP Online Curriculum on LGBT Mental Health Serena Y. Volpp, M.D.
C.
The Psychiatrist as Advocate: The Case of AGLP Ubaldo Leli, M.D.
D.
The GAP Online Curriculum on LGBT Mental Health Vernon A. Rosario, M.D.
E.
A Picture's Worth a Thousand Words: Using Film for Mental Health Advocacy and Activism Alicia Salzer, M.D.
F.
Talking to the Media: Teaching Psychiatrists to Embrace the Sound Bite Jack Drescher, M.D.
S60. The Public Health and Clinical Interface Between HIV, STDs, and Mental Health
A.
The Public Health Interface Between HIV, Sexually Transmitted Diseases, and Mental Illness Marc Safran, M.D.
B.
The Clinical Interface Between HIV, Sexually Transmitted Diseases, and Mental Illness Marshall Forstein, M.D.
C.
The Impact of Neuropsychiatric Syndromes on the Course of Treatment in HIV Stephen Ferrando, M.D.
S61. Adolescent Potential: Exploring the Developing Brain and Understanding Pathways of Addiction National Institute on Drug Abuse
A.
The Developing Brain, Adolescence, and Alcohol/Drug Use: An Evolutionary Approach Linda Spear, Ph.D.
B.
The Teen Brain: Insights From Neuroimaging Jay N. Giedd, M.D.
C.
Vulnerabilities in Adolescent Decision Making: Neuroimaging Evidence of Immaturities in Cognitive Control, Reward Processing, and Brain Connectivity Beatriz Luna, Ph.D.
D.
Brain Functioning in Adolescent Substance Using Boys and Girls Susan F. Tapert, Ph.D.
S62. The 2010 APA Task Force Report on the Practice of Electroconvulsive Therapy: Evidence-Based Guidelines for the Practicing Clinician APA Council on Research and Quality Care
A.
The History of the Classification of ECT and the Challenges for the Future Richard Weiner, M.D.
B.
The Medical Evaluation and Consent Process for Patients Undergoing ECT Husain Mustafa, M.D.
C.
Optimal Electrode Placement in the Administration of ECT Sarah H. Lisanby, M.D.
D.
Emerging Data on the Importance of Pulse Width in ECT Joan Prudic, M.D.
E.
Maintenance Treatment in ECT Charles Kellner, M.D.
S63. DSM-5 Examined: Nosology of Mood Disorders
A.
How Do We Classify the Mood Disorders? Michael A. Schwartz, M.D.
B.
Depression: When Sadness Is “Lost,” What Is Gained? Peter D. Kramer, M.D.
C.
Pediatric Bipolar Disorder: More Than a Social Construction, Less Than a Natural Kind Peter Zachar, Ph.D.
D.
Major Depressive Disorder Deconstructed: Neurotic Depression and Mixed States S. Nassir Ghaemi, M.D.
E.
An Update From the DSM-5 Work Group on Mood Disorder: A Focus on Bipolar Symptoms Trisha Suppes, M.D.
S64. DSM-5 Update Series, Part II: Reports From the Work Groups
A.
Balancing Conservation and Innovation in DSM-5: Update on Attention-Deficit/Hyperactivity Disorder F. Xavier Castellano, M.D.
B.
Reconsidering the Disruptive Behavior Disorders for DSM-5 David Shaffer, M.D.
C.
Developing a New Model of Personality Disorders for DSM-5 Andrew E. Skodol, M.D.
S65. Revisiting Pharmacological Treatments to Prevent Suicide
A.
The Evidence for and Potential Impact of Clozapine on Suicide Risk in Schizophrenia: So How Do We Get Psychiatrists to Prescribe It? Herbert Y. Meltzer, M.D.
B.
Mortality in Schizophrenia: An 11-Year Follow-Up Study of the Total Finnish Population (Fin11 Study) Kristian Wahlbeck, M.D.
C.
Association Between Consistent Purchase of Anticonvulsants or Lithium and Suicide Risk: A Longitudinal Cohort Study From Denmark, 1995-2001 Eric Smith, M.D., M.P.H.
D.
Translating Suicide Endophenotypes Shared Between Humans and Mice: Novel Strategies to Understand the Mechanism Underlying Lithium's Anti-Suicidal Efficacy Todd D. Gould, M.D.
S66. Reward Neurocircuitry in Substance Dependence and Other Psychiatric Disorders: What Does Brain Research Tell Us? National Institute on Drug Abuse
A.
Reward Neurocircuitry in Preclinical Models: Foundations and Alterations With Drug Use Susan R. Sesack, Ph.D.
B.
Functional Neuroimaging of Neural Circuits Regulating Aversive Emotional Reactions and Expectations of Reward Mauricio Delgado, Ph.D.
C.
Neuroimaging Studies of Reward Processing in Major Depressive Disorder Wayne C. Drevets, M.D.
D.
Association of Nicotine Addiction and Nicotine's Actions With Separate Cingulate Cortex Functional Circuits Elliot Hong, M.D.
E.
PET Evaluation of Neurocircuitry Related to Etiology and Treatment of ADHD James M. Swanson, Ph.D.
9 a.m.-4 p.m.
CME Courses 69-74
10 a.m.-6 p.m.
Exhibits Open
APA Member Center Open
Publishers' Bookfair Open
11 a.m.-12:30 p.m.
Advances in Medicine
AM04. Aging and Dementia: A n Update on Neuroscience and Brain Imaging Anne L. Foundas, M.D.
Case Conference
S. Charles Schulz, M.D., on Helping Parents of a First-Episode Psychotic Patient (Open to APA members only.)
Lectures
L13. Highlights and Lessons From 40 Years in Psychiatry Eve C. Johnstone, M.D.
L14. Comorbidity of Psychiatric Disorders Ronald C. Kessler, Ph.D.
Small Interactive Sessions
SI14. Elissa P. Benedek M.D., on Principles and Practice of Child and Adolescent Forensic Mental Health (Meet the Author) National Institute on Drug Abuse
SI15. Nora D. Volkow, M.D., on Addiction and the Brain
SI16. Paul S. Sppelbaum, M.D., on Ethical Issues in Psychiatry
SI17. David Mrazek, M.D., on Psychiatric Pharmacogenomics
SI18. Elspeth C. Ritchie M.D., on Psychiatric Issues Related to Returning Vets From Iraq and Afghanistan
Scientific and Clinical Reports
Session 15. Information Technology
SCR43. Web-Based Access to Medicaid Data to Support the Implementation of Best Practices in Pharmacotherapy in a Large-Scale Quality Improvement Initiative Molly Finnerty, M.D.
SCR44. PSYCKES: Web-Based Access to Medicaid Data to Support the Implementation of Best Practices in Pharmacotherapy in a Large-Scale Quality Matthew Perkins, M.D.
SCR45. International Telepsychiatry in Cross-Cultural Related Mental Health Care Davor Mucic, M.D.
Session 16. Side Effects of Psychotropic Medication
SCR46. Risk of Low Bone Mineral Density Associated With Psychotropic Medications and Mental Disorders: A Population-Based Analysis James Bolton, B.S.C., M.D.
SCR47. Metabolic Syndrome in Psychiatric Inpatients: The Role of Valproate and Lithium Bonnie Szarek, R.N.
SCR48. A Novel, Patient-Rated Scale for Side Effects: Prospective Proof of Concept Study Rajnish Mago, M.D.
Workshops
W93. Ethical Dilemmas in Psychiatric Practice Ethics Committee Chair: Wade Myers, M.D.
W94. Boundary Crossings as Boundary Accommodations: The Physician/Patient Relationship With Medically Ill Patients Chair: James Lomax, M.D.
W95. A Resident's Guide to Borderline Personality Disorder: From the Experts (Part II) Chair: John Gunderson, M.D. (Open to residents only.)
W96. Psychiatric Professional Liability 2009: The Year in Review Co-Chairs: Donna Vanderpool, J.D., Martin Tracy, J.D.
W97. The Train Has Left the Station: National Incentives and Developments in Electronic Health Records Chair: Laura Fochtmann, M.D.
W98. Cognitive Therapy for Psychosis in Practice: Basic Techniques for Psychiatrists Chair: Shanaya Rathod, M.D.
Noon-2 p.m.
New Research Poster Session 4
1 p.m.-5 p.m.
CME Courses 75-76
1:30 p.m.-3 p.m.
Advances in Medicine
AM05. Medical Mysteries and Practical Medical Psychiatric Updates: Is It Medical, Psychiatric, or a Little of Both? Chair: Robert M. McCarron, D.O.
Lectures
L15. Outside Lecture Andrew T. McClellan, Ph.D., National Institute on Drug Abuse
L16. Oskar Pfister Award Lecture George E. Vaillant, M.D.
Scientific and Clinical Reports
Session 17. Weight Gain and Psychiatric Illness
SCR49. Biochemical Risk Factors for Development of Obesity in First-Episode Schizophrenia Robert Bodén, M.D.
SCR50. Relationship Between Cholesterol Levels and Cognitive Function in Patients With Schizophrenia Randomized to Clozapine, Olanzapine, and Haloperidol Menahem Krakowski, M.D.
SCR51. Oatmeal v. Donuts: Treating Metabolic Syndrome/Obesity Using CBT/DBT in an Inner-City SPMI Population Joanne Caring, M.D.
Session 18. Suicide
SCR52. The Relationship Between Anxiety Disorders and Suicide Attempts: Findings From the National Epidemiologic Survey on Alcohol and Related Conditions James Bolton, B.S.C., M.D.
SCR53. Religion, Spirituality, and Risk of Suicidal Ideation and Attempts: An Epidemiological Perspective Daniel Rasic, B.S., M.D.
SCR54. A Multi-Site Review of Post-discharge Suicides Virginia L. Susman, M.D.
Session 19. Attention Deficits and Psychostimulants
SCR55. Double-Blind, Placebo-Controlled Efficacy and Safety Study of Lisdexamfetamine Dimesylate in Adolescents With Attention-Deficit/Hyperactivity Disorder Ann Childress, M.D.
SCR56. Is Deficient Emotional Self-Regulation a Comorbid or Integral Feature of Attention-Deficit/Hyperactivity Disorder in Adults? A Controlled Study Craig Surman, M.D.
SCR57. Adjunctive Armodafinil for Major Depression Associated With Bipolar I Disorder: A Randomized, Double-Blind, Placebo-Controlled Study Joseph Calabrese, M.D.
Workshop
W99. Responding to the Impact of Suicide on Clinicians Chair: Eric M. Plakun, M.D.
2 p.m.-5 p.m.
Advances in Series
A07. Advances in Substance Abuse Treatment Co-Chairs: Marc Galanter, M.D., Herbert D. Kleber, M.D.
A08. Advances in Personality Disorders Co-Chairs: John M. Oldham, M.D., Andrew E. Skodol, M.D.
Media Workshop
MW5. Novel Programs to Promote Mental Wellness in Medical Students American Foundation for Suicide Prevention Co-Chairs: Julie Chilton, M.D., Leah Dickstein, M.D.
Presidential Symposium
PS07. To Be Announced Chair: Harold A. Pincus, M.D.
Symposia
S67. Implementing the STEPPS* Program for Borderline Personality Disorder (*Systems Training for Emotional Predictability and Problem Solving)
A.
Implementing the STEPPS Program in Iowa Prisons Nancee Blum, M.S.W.
B.
VERS: a Randomized, Controlled Trial of a Dutch Version of STEPPS for Borderline Personality Disorder Bas van Wel, M.D.
C.
Implementing STEPPS in t he United Kingdom Renee Harvey, M.A.
D.
Emotion Regulation Training (An Adaptation of STEPPS) for Adolescents With Borderline Personality Symptoms Marieke Schuppert, M.D.
S68. Evidence-Based Treatments (EBT) for Borderline Personality Disorder: Empirical Clarity Meets Clinical Reality
A.
Integrating Metallization-Based Treatment With Other Evidence-Based Treatment With Other Treatments for Borderline Personality Disorder: Lethal Cocktail or Super Therapy? Anthony Bateman, M.D.
B.
Development and Implantation of Transference-Focused Psychotherapy (TFP) Otto Kernberg, M.D.
C.
Dialectical Behavioral Therapy and Metallization-Based Treatment: An Integration of Two Empirically Validated Treatments for BPD Lois Choi-Kain, M.D.
D.
The Trials and Tribulations of Implementing Dialectical Behavior Therapy Joan Whellis, M.D.
S69. The Nuts and Bolts of the Perinatal Psychiatric Consultation
A.
Evaluation of Mood and Anxiety Disorders During Pregnancy and the Postpartum Period Ruta M. Nonacs, M.D.
B.
Staying Informed and Afloat: How to Approach Evidence-Based Practice in the Psychiatric Treatment of Pregnant and Postpartum Patients Elizabeth M. Fitelson, M.D.
C.
Psychotherapy Treatments Margaret Spinelli, M.D.
D.
The Perinatal Psychiatric Consultation: Medication Treatment Adele Viguera, M.D.
E.
Putting It All Together: The Last Movement of the Perinatal Psychiatric Consultation Kristin Leight, M.D.
S70. The Potential and Pitfalls of Creating a Bipolar Genomic Biobank
A.
Mayo Clinic Individualized Medicine Biobank for Bipolar Disorder: Overview Joachim Benitez, M.D.
B.
Antidepressant-Induced Mania: The Need for Rigorous Phenotypic Assessment Mark Frye, M.D.
C.
Retrospective Pharmacogenomic Treatment Response Susan McElroy, M.D.
D.
Advocacy Collaboration Into Biobanks Allen Daniels, Ed.D.
E.
Biobanking: New Ethical Challenges? Barbara A. Koenig, Ph.D.
S71. The Treatment of Psychiatric Disorders With rTMS: New Research and Clinical Findings
A.
Repetitive Transcranial Magnetic Stimulation for Auditory Hallucinations in SCZ Zafiris J. Daskalakis, M.D.
B.
Transcranial Magnetic Stimulation (TMS) for Major Depression: Past, Present, and Future Challenges Yechiel Y.L. Levkovitz, M.D.
C.
Can rTMS Help Obsessive Compulsive Disorder? Peggy Richter, M.D.
D.
A Meta-Analytic Study Evaluating Brain Activation and Response to rTMS in Anorexia Nervosa Allan S. Kaplan, M.D., Kate Strasburg, M.D.
S72. The Tattered Safety Net: The Public Mental Health Crisis in an Economic Recession APA Council on Minority Mental Health and Health Disparities
A.
Who Cares? Can We Afford to Reduce Expenditures for Mental Health Services in Times of Need? Anita S. Everett, M.D.
B.
The Economic Downturn, Mental Health, Mental Illness: Prospects for Recovery Kenneth Thompson, M.D.
C.
Mental Health Consequences of the U.S. Economic Downturn: What Do We Know and What Can Be Done? Lisa M. Bates, S.M.
D.
Sacramento County, Calif., Budget Cuts, Work Arounds, and Unintended Consequences Russell F. Lim, M.D.
E.
Adding Insult to Injury: The Public Mental Health Crisis in Regions of Long-Term Economic Stagnation Patrick S. Runnels, M.D.
F.
An Action Plan for Public Mental Health During an Economic Recession David A. Pollack, M.D.
S73. Lessons From Hurricane Katrina: Response, Recovery, and Rebuilding
A.
Charting the Course of Recovery From Mental Disorders in Hurricane Katrina Ronald C. Kessler, Ph.D.
B.
The Federal Crisis Counseling Program: Lessons From New Orleans Kenneth Thompson, M.D.
C.
Louisiana Spirit: Catastrophic Impact and Psychological Recover y Anthony Speier, Ph.D.
D.
Mental Health and Recovery Following Hurricane Katrina Howard J. Osofsky, M.D.
E.
Mental Health and Recovery Following Hurricane Katrina Joy D. Osofsky, Ph.D.
S74. Toward a New Model for Mental Health Services in the University Community APA Council on Children, Adolescents, and Their Families
A.
The Need for a Community Mental Health Model Paul J. Barreira, M.D.
B.
Contributions From the Public Health Orientation Laurie Davidson, M.A.
C.
Integrating the Student's Family Into College Mental Health Kristine A. Girard, M.D.
D.
The Campus as Community: Working With Administration Lorraine D. Siggins, M.D.
E.
Psychiatry Residents in the College Mental Health Service Jerald Kay, M.D.
S75. DSM-5 Update Series, Part III: Reports From the Work Groups
A.
DSM-5 Update on Anxiety Disorders and Obsessive-Compulsive Spectrum Disorders Katharine A. Phillips, M.D.
B.
Major Issues Concerning Mood Disorders in DSM-5 Jan Fawcett, M.D.
C.
Anticipating DSM-5: Schizophrenia and Related Psychoses William T. Carpenter, M.D.
D.
Looking Toward DSM-5: PTSD and Dissociative Disorders Matthew J. Friedman, M.D.
E.
Update From the Mood Disorders Work Group, Bipolar Disorder Subcommittee Trisha Suppes, M.D.
S76. The Challenge of Cognitive Enhancers in Medicine National Institute on Drug Abuse
A.
5 HT Receptors as Targets for Cognitive Enhancement in Schizophrenia Herbert Y. Meltzer, M.D.
B.
ADHD Treatment, Comorbidity With SUDs, and COGS-Related Diversion Nora D. Volkow, M.D.
C.
Modafinil's Abuse Potential and Possible Role in Cocaine Dependence Charles Dackis, M.D.
D.
Nonimpaired Elders, Cognitive Enhancers, and the Boundaries of Usual and Customary Practice James M. Ellison, M.D.
E.
Pharmacological Cognitive Enhancement in Neuropsychiatric Disorders and in Healthy People Barbara Sahakian, M.D.
S77. Sex and Psychodynamics: Contemporary Approaches to Clinical Issues Through the Lifecycle American Academy of Psychoanalysis and Dynamic Psychiatry
•.
A. Breaking the Silence: Discussing Sex With Teens in Psychotherapy Eugene Beresin, M.D.
•.
B. Psychodynamics of Hypersexuality in Children and Adolescents With Bipolar Disorder Stewart L. Adelson, M.D.
•.
C. Driven Sexual Behavior in Adults With “Soft Bipolarity”: A Psychodynamic Perspective Jennifer I. Downey, M.D.
•.
E. The Role of Sexual History Taking in Improving Psychotherapeutic Treatment Matthew Neltner, M.D.
•.
F. Menopause, Depression, and Decreased Sexual Desire: A Psychodynamic Contribution Sherry P. Katz Bearnot, M.D.
S78. Progress and Promise: Preventing the First Episode of Psychosis
A.
Cognitive and fMRI Studies in Clinical High Risk and Early Psychosis: Understanding Mechanisms and Predicting Risk Carter S. Cameron, M.D.
B.
Pattern of Neurocognitive Deficits in Individuals at Clinical High Risk for Psychosis Barbara Cornblatt, Ph.D.
C.
Transitioning From First Episode to Prodrome: Learning From the EAsT Program Robert Wolf, M.D.
D.
Portland Identification and Early Referral (PIER): Conversion and Incidence Outcomes in a Catchment Area-Wide Psychosis Prevention Program William R. McFarlane, M.D.
S79. Reproductive Issues and Women's Mental Health: How to Untie the Gordien Knot?
A.
Why Psychiatry and Abortion? Nada L. Stotland, M.D.
B.
Dilemmas Concerning Miscarriage and Genetic Terminations Gail E. Robinson, M.D.
C.
The Right to Health: The Need to Uphold Sexual and Reproductive Health to Promote Mental Health in Latin America Marta B. Rondon, M.D.
D.
What If Motherhood Cannot Chase All the Blues Away? Gisèle Apter, M.D.
S80. Treatment of Depression With TMS: An Overview of Findings From the Optimization of TMS for the Treatment of Depression Trial (Opt TMS)
A.
Introduction and State of the Current Practice and Knowledge Mark S. George, M.D.
B.
Clinical Results From the Randomized OPT TMS Trial Paul Holtzheimer, M.D.
C.
How Do These Results Relate to Clinical Practice and How Do We Decide Who to Treat and for How Long? William M. McDonald, M.D.
D.
How Do You Create a TMS Sham? Sarah H. Lisanby, M.D.
E.
How Long Do the TMS Clinical Effects Last? Antonio Montavani, M.D.
F.
How Does Prefrontal TMS Work to Treat Depression? Ziad H. Nahas, M.D.
S81. Mood, Memory, and Myths: What Really Happens at Menopause?
A.
Depression and Other Symptoms: Risks in the Transition to Menopause Ellen Freeman, Ph.D.
B.
Hot Flashes and Sleep Disturbances During Menopause Transition: Exploring Effective Treatment Strategies Claudio N. Soares, M.D.
C.
Sexuality in Transition: Menopause and Aging Anita H. Clayton, M.D.
D.
Where Did I Put My Keys? The Ongoing Saga of Estrogen, Serotonin, Mood, and Memory at Menopause C. Neill Epperson, M.D.
3 p.m.-5 p.m.
New Research Poster Session 5
3:30 p.m.-5 p.m.
Scientific and Clinical Reports
Session 20. Inpatient Psychiatry: Admissions and Readmissions
SCR 58. The Association Between Preadmission Suicidality and Readmission Is Modified by Patient Experiences, Feelings, and Characteristics Stephen Woolley, D.Sc., M.P.H.
SCR 59. Effectiveness of Peer Support in Reducing Readmissions Among People With Multiple Psychiatric Hospitalizations William Sledge, M.D.
SCR 60. Inpatients With Versus Nonpsychotic MDD: Prevalence and Clinical Characteristics John Goethe, M.D.
Session 21. Scales and Screening Measures
SCR 61. Feasibility and Effectiveness of Using E-mail to Screen College Students for Depression Irene Shyu, B.A.
SCR 62. The Valuation of Impairment: Relative Values on the Psychiatric Impairment Rating (PIRS) Subscales Gordon Davies, M.B., B.S.
SCR 63. Are Screening Scales for Bipolar Disorder Good Enough to Be Used in Clinical Practice? Mark Zimmerman, M.D.
Workshop
W100. Ethical Challenges in End-of-Life Care in the Hospitalized Elderly Chair: Maria Lapid, M.D.
Lecture
L17. Simon Bolivar Award Lecture American Society of Hispanic Psychiatry; Maria Oquendo, M.D.
7 p.m.-10 p.m.
Media Workshop
MW6. “Boy Interrupted” Co-Chairs: Nancy Rappaport, M.D., Joanne Harpel, J.D. 
Information & Authors
Information
Published In
History
Published online: 19 February 2010
Published in print: February 19, 2010
Authors
Metrics & Citations
Metrics
Citations
Export Citations
If you have the appropriate software installed, you can download article citation data to the citation manager of your choice. Simply select your manager software from the list below and click Download.
For more information or tips please see 'Downloading to a citation manager' in the Help menu.
There are no citations for this item
View Options
View options
Get Access
Login options
Already a subscriber? Access your subscription through your login credentials or your institution for full access to this article.
Personal login Institutional Login Open Athens loginNot a subscriber?
PsychiatryOnline subscription options offer access to the DSM-5-TR® library, books, journals, CME, and patient resources. This all-in-one virtual library provides psychiatrists and mental health professionals with key resources for diagnosis, treatment, research, and professional development.
Need more help? PsychiatryOnline Customer Service may be reached by emailing [email protected] or by calling 800-368-5777 (in the U.S.) or 703-907-7322 (outside the U.S.).